MedTrace Logo

Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study

NCT06719206 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2026-01-30

No results posted yet for this study

Summary

Summary

Reducing sedentary behavior during treatment is important to reduce the risk of future health problems in individuals undergoing cancer treatment. Therefore, the goal of this project is with a multicenter randomised controlled design investigate whether a digital support intervention during ongoing neo- or adjuvant cancer treatment for breast, prostate or colon cancer is effective in reducing sedentary lifestyle and improving well-being in the short and long term.

Conditions

Interventions

BEHAVIORAL

Digital self-management program

The program consists of commercially available technologies, e.g. applications including behavour change techniques for reducing sedentary behavior (SB) (i.e. self-monitorization of physical activity, reminders for breaking SB/doing physical activity, and providing feedback on physical activity/breaks from SB) and a webpage containing information and tips (provided in short videos and text) regarding how to reduce SB. The participants will be receive help with setting goals for reducing time spent in sedentary/being active and help with planning for what activities to do to replace time in sedentary. Participants will then have access to the webpage and download the application to their smartphones. Follow-up meetings with the physiotherapist (digital or physical) will be conducted after 2, 8 and 12 weeks after start of intervention.

Sponsors & Collaborators

  • Region Västmanland

    collaborator OTHER

  • Uppsala University

    collaborator OTHER

  • Centrallasarettet Västerås

    collaborator OTHER

  • Uppsala University Hospital

    collaborator OTHER

  • Uppsala County Council, Sweden

    collaborator OTHER_GOV

  • Mälardalen University

    lead OTHER

Principal Investigators

  • Petra von Heideken Wågert, Professor · Mälardalen University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06719206 on ClinicalTrials.gov